Sana Biotechnology has got some major backing after coming out with a huge $700 million initial funding round and the ex-financial and research team from Juno Therapeutics.
When you spend $63 billion on a company, your hope is that investment will come back; sometimes, however, you get hit with problems.
Washington, DC – (June 26, 2020) – The Biotechnology Innovation Organization (BIO) today announced winners of the Start-up Stadium competition held during BIO Digital in June. Pre-recorded ...
Vaxart, a small-cap biotechnology company focused on developing oral vaccines administered by tablet rather than injection, said on Friday that ...
As two of Germany’s brightest COVID-19 pandemic vaccine biotechs continue to speed on with their clinical work, both have seen big cash injections to help them—but from very different ...
We are sharing the incredible achievements from our 2020 VC winners through a blog series highlighting the award recipients’ work. Read our interview with Dr. Beth Seidenberg, winner of the ...
Covid-19 is a double whammy—killing over half a million people and simultaneously derailing the global economy. Berkeley Lights is working out the antidote on both fronts, fast-tracking ...
The Massachusetts Biotechnology Council (MassBio®) today released its State of Possible 2025 Report, a five-year strategic plan to define the future direction of the Massachusetts life ...